Forensic Analysis · Automotive / Vehicle Manufacturing · as of Sep 25, 2026
Aeva Technologies, Inc. (AEVA)
A forensic read on Aeva Technologies, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
-7.5
Distress distance
Clean
Earnings quality
5
Forensic signals
-74.0
P / E (ttm)
-1100.5%
ROE
$1.1B
Market cap
0.00%
Dividend yield
99.4%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Aeva Technologies, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -7.5, placing it in the Distress zone. 5 forensic signals were flagged in its latest SEC filings, led by inventory days.
What the filings flag
79d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 67 to 79 FY2024→FY2025 (against cost of goods sold; inventory +147% vs +46% in cost of sales). Inventory is outrunning what's being sold — a flag for softening demand or obsolescence risk ahead.
+12.1%/yr
FY2023–FY2025
Share-count dilution.Diluted share count changed +26% over the last 2 years to FY2025 (+12.1%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~12.1% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~20%.
n/m (sign flip)
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets flipped from positive to negative FY2024→FY2025 (FY2024 $+70.5M to FY2025 $-59.1M) — the standard accruals ratio divides by the average of the two, which collapses toward zero right as the sign changes, so the resulting percentage is a denominator artifact, not a real accrual measurement. Treat this as a structural balance-sheet shift to understand on its own terms rather than a clean or dirty accruals read.
68d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 48 to 68 days FY2024→FY2025 (receivables +183% vs revenue +99%). Receivables are creeping up relative to sales. Across FY2023–FY2025 the day count ran 53 → 48 → 68 days, so the latest reading sits on top of a record that was flat or falling before it — one year's move, not a direction the business has been travelling in. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2024's opening balance is on file, but across the 3 fiscal years read here (FY2023–FY2025) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.
Key fundamentals
Latest Revenue$18.1M
Revenue Growth YoY+99.4%
Revenue CAGR (2yr)+104.7%
Net Margin-804.4%
Free Cash Flow-$119.7M
Return on Equity-1100.5%
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Aeva Technologies, Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 25, 2026. Forensic signals flag probability, not certainty.
Aeva Technologies, Inc. (AEVA) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy
121% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 121% of revenue in FY2025 — about $0.38 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 12.2% a year, and the rate is falling. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.